Acorda Therapeutics Inc 1 éves cél

Mi az Acorda Therapeutics Inc 1 éves cél?

A 1 éves cél az Acorda Therapeutics Inc - $2 +253.03%

Mi a 1 éves cél meghatározása?

Az 1 évre szóló cél az előrejelzett tőzsdei ár egy év múlva.

One year target is an estimate of a stock price for a point in time equal to a year from the current date. The price level most often reflects the collective opinion of different analysts on where the stock will be trading a year from now. For an analyst to identify an individual estimate, they have to project what a company’s business will look like in a year, typically focusing on revenue and other significant factors. They also consider the willingness of investors to pay a certain price. While the average or median recommendation may be predictive and reflect the actual future value, the results are usually not extremely successful.

1 éves cél a Health Care szektor a NASDAQ-on cégekben a Acorda Therapeutics Inc -hoz képest

Mit csinál Acorda Therapeutics Inc?

acorda therapeutics is a publicly traded (nasdaq: acor) biotechnology company whose mission is to develop therapies that restore neurological function and improve the lives of people with neurological disorders. we started our company in 1995 as a network of scientists, physicians and business people with a common belief that sharing ideas and information could lead to innovative medical advances for people with neurological disorders. we have since evolved into a commercial-stage biotechnology company, successfully developing and commercializing important therapies that advance the care of people affected by neurological conditions. we achieve our goals by: • investing in research and development • collaborating closely with the patient, medical and scientific communities • retaining employees with compassion and commitment acorda has been voted one of the best companies to work for in new york for the past five years in a row, as a result of our dynamic environment, strong corporate

1 éves cél -hoz hasonló cégek Acorda Therapeutics Inc